Global Endocrinology and Metabolism market is projected to reach US$ 173930 million by 2030, at 12.1% CAGR | Prospect Research Reports
Global Endocrinology and Metabolism Market, valued at $77.73 billion in 2023, is projected to grow to $197.56 billion by 2033, at a CAGR of 12.1%. This growth is driven by the rising prevalence of endocrine diseases like diabetes, obesity, and thyroid disorders, along with an aging population, sedentary lifestyles, and poor eating habits. The market includes products for diagnostic tests, medications, and treatments targeting hormonal and metabolic imbalances. Key market segments include diabetes drugs, HGH treatments, and thyroid hormone therapies, with demand spread across hospital pharmacies, retail pharmacies, and online pharmacies. Major players in the market include Eli Lilly, Abbott Laboratories, and Hoffmann-La Roche. The market is seeing increasing investment in innovation to meet the growing healthcare needs of patients worldwide.
Click for Free Sample Report with All Related Graphs &
Charts: https://prospectresearchreports.com/report/423703?type=request_sample
Latest Study on Industrial Growth of Global Endocrinology and Metabolism
Market 2025-2033. A comprehensive study accumulated to offer Latest insights
about acute features of the Global Endocrinology and Metabolism
Market. The report contains different market predictions related to revenue
size, production, CAGR, Consumption, gross margin, price, and other substantial
factors. While emphasizing the key driving and restraining forces for this
market, the report also offers a complete study of the future trends and
developments of the market. It also examines the role of the leading market
players involved in the industry including their corporate overview, financial
summary, and SWOT analysis.
The
Market available for 2025-2033
Base Year - 2024
Forecast Period - 2025-2033.
Click for
Customization Report: https://prospectresearchreports.com/report/423703?type=request_customization
Definition: Endocrinology is a branch of
medicine focused on the diagnosis, treatment, and management of disorders
related to the endocrine system, which involves glands and organs that
produce hormones. Hormones are chemical messengers that regulate numerous
bodily functions, including metabolism, growth, reproduction, and mood. The endocrine
glands include the pituitary, thyroid, parathyroid, adrenal
glands, pancreas, and gonads (ovaries and testes). Disorders
in this system can lead to a range of conditions, including diabetes, thyroid
diseases, obesity, and metabolic disorders such as hypo-
and hyperthyroidism, Cushing's syndrome, and Addison's disease.
Metabolism refers to the set of life-sustaining
chemical reactions within the body that allow cells to convert food into
energy, grow, and repair themselves. Metabolic disorders involve
abnormalities in the processes by which the body converts or stores energy,
leading to conditions like diabetes, obesity, and hyperlipidemia.
In summary,
endocrinology is the study of how hormones influence health and disease, and
the field is crucial for managing diseases that result from hormonal imbalances
or dysfunctions in the endocrine glands.
Key Players: Abbott Laboratories, Acerus Pharmaceuticals Corp.,
Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co.,
Endo International Plc, Hoffmann-La Roche Ltd., GlaxoSmithKline Plc (GSK),
Hanmi Pharm Co. Ltd., Ipsen Pharma, etc.
These companies dominate the
Global Endocrinology and Metabolism Market,
offering both innovative treatments and solutions to help manage chronic
endocrine and metabolic diseases such as diabetes, thyroid disorders, and obesity. The market is expected
to grow significantly due to the rising prevalence of these conditions, and
these companies are well-positioned to benefit from this expansion.
Click for free PDF Sample Report: https://prospectresearchreports.com/report/423703?type=request_sample
Global Endocrinology and Metabolism Market research study by Prospect
Research Reports offers detailed outlook and elaborates
market review till 2033. The market Study is segmented by key regions that are
accelerating the marketization. At present, the market players are strategizing
and overcoming challenges of current scenario. The latest edition of this
report you will be entitled to receive additional chapter / commentary on latest
scenario, economic slowdown and COVID-19 impact on overall industry. Further it
will also provide qualitative information about when industry could come back
on track and what possible measures industry players are taking to deal with
current situation. Each of the segment analysis table for forecast period also
high % impact on growth.
Have Any Questions Regarding Global Endocrinology and Metabolism Market Report, Ask Our Experts: Lokesh Bhadra
lokesh@prospect-researchreports.com
For more
Information, Request for Full Report: https://prospectresearchreports.com/reports/423703/endocrinology-and-metabolism-market
This report will give you an unmistakable perspective on
every single reality of the market without a need to allude to some other
research report or an information source. Our report will give all of you the
realities about the past, present, and eventual fate of the concerned Market.
Thanks for reading this article, we can also provide customized report
as per company’s specific needs. You can also get separate chapter wise or
region wise report versions including North America, Europe or Asia.
#Endocrinology #MetabolicDisorders #Diabetes #Obesity #Thyroid Disorders #HormonalImbalance #HumanGrowthHormone(HGH) #ThyroidHormoneDisorders #HealthcareMarket #EndocrineGlands #Pharmaceuticals #HospitalPharmacies #RetailPharmacies #OnlinePharmacies #EliLilly #AbbottLaboratories #Biocon #Hoffmann-LaRoche #EndocrineDiseases #AgingPopulation #MetabolicDiseases #HealthcareNeeds.
Contact US:
8 Pilkington Close,
Stoke Gifford Bristol,
United Kingdom, BS34 8JU
+44-77-6742-7537
Comments
Post a Comment